AAAAAA

   
Results: 1-22 |
Results: 22
Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection
Authors: Bassett, SE Guerra, B Brasky, K Miskovsky, E Houghton, M Klimpel, GR Lanford, RE
Citation: Se. Bassett et al., Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection, HEPATOLOGY, 33(6), 2001, pp. 1479-1487
Folding of hepatitis C virus E1 glycoprotein in a cell-free system
Authors: Merola, M Brazzoli, M Cocchiarella, F Heile, JM Helenius, A Weiner, AJ Houghton, M Abrignani, S
Citation: M. Merola et al., Folding of hepatitis C virus E1 glycoprotein in a cell-free system, J VIROLOGY, 75(22), 2001, pp. 11205-11217
Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity
Authors: Weiner, AJ Paliard, X Selby, MJ Medina-Selby, A Coit, D Nguyen, S Kansopon, J Arian, CL Ng, P Tucker, J Lee, CT Polakos, NK Han, J Wong, S Lu, HH Rosenberg, S Brasky, KM Chien, D Kuo, G Houghton, M
Citation: Aj. Weiner et al., Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity, J VIROLOGY, 75(15), 2001, pp. 7142-7148
Hepatitis C virus-specific CD4(+) T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease
Authors: Schirren, CA Jung, MC Worzfeld, T Mamin, M Baretton, G Gerlach, JT Gruener, NH Zachoval, R Houghton, M Rau, HG Pape, GR
Citation: Ca. Schirren et al., Hepatitis C virus-specific CD4(+) T cell response after liver transplantation occurs early, is multispecific, compartmentalizes to the liver, and does not correlate with recurrent disease, J INFEC DIS, 183(8), 2001, pp. 1187-1194
Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine
Authors: Polakos, NK Drane, D Cox, J Ng, P Selby, MJ Chien, D O'Hagan, DT Houghton, M Paliard, X
Citation: Nk. Polakos et al., Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine, J IMMUNOL, 166(5), 2001, pp. 3589-3598
Hepatitis C virus and eliminating post-transfusion hepatitis
Authors: Alter, HJ Houghton, M
Citation: Hj. Alter et M. Houghton, Hepatitis C virus and eliminating post-transfusion hepatitis, NAT MED, 6(10), 2000, pp. 1082-1086
Effect of IL-12 on T-cell immune responses in patients with chronic HCV infection
Authors: Fan, XG Tang, FQ Yi, H Liu, WE Houghton, M Hu, GL
Citation: Xg. Fan et al., Effect of IL-12 on T-cell immune responses in patients with chronic HCV infection, APMIS, 108(7-8), 2000, pp. 531-538
Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma
Authors: Schirren, CA Jung, MC Gerlach, JT Worzfeld, T Baretton, G Mamin, M Gruener, NH Houghton, M Pape, GR
Citation: Ca. Schirren et al., Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma, HEPATOLOGY, 32(3), 2000, pp. 597-603
Priming of hepatitis C virus-specific cytotoxic T lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
Authors: Lee, AY Manning, WC Arian, CL Polakos, NK Barajas, JL Ulmer, JB Houghton, M Paliard, X
Citation: Ay. Lee et al., Priming of hepatitis C virus-specific cytotoxic T lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA, HEPATOLOGY, 31(6), 2000, pp. 1327-1333
Quantification of the number of cytotoxic T cells specific for an immunodominant HCV-specific CTL epitope primed by DNA immunization
Authors: Lee, AY Polakos, NK Otten, GR Ulmer, JB Houghton, M Paliard, X
Citation: Ay. Lee et al., Quantification of the number of cytotoxic T cells specific for an immunodominant HCV-specific CTL epitope primed by DNA immunization, VACCINE, 18(18), 2000, pp. 1962-1968
Strategies and prospects for vaccination against the hepatitis C viruses
Authors: Houghton, M
Citation: M. Houghton, Strategies and prospects for vaccination against the hepatitis C viruses, CURR T MICR, 242, 2000, pp. 327-339
Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates
Authors: Heile, JM Fong, YL Rosa, D Berger, K Saletti, G Campagnoli, S Bensi, G Capo, S Coates, S Crawford, K Dong, C Wininger, M Baker, C Cousens, L Chien, D Ng, P Archangel, P Grandi, G Houghton, M Abrignani, S
Citation: Jm. Heile et al., Evaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates, J VIROLOGY, 74(15), 2000, pp. 6885-6892
Structure-function analysis of hepatitis C virus envelope-CD81 binding
Authors: Petracca, R Falugi, F Galli, G Norais, N Rosa, D Campagnoli, S Burgio, V Di Stasio, E Giardina, B Houghton, M Abrignani, S Grandi, G
Citation: R. Petracca et al., Structure-function analysis of hepatitis C virus envelope-CD81 binding, J VIROLOGY, 74(10), 2000, pp. 4824-4830
Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81
Authors: Allander, T Drakenberg, K Beyene, A Rosa, D Abrignani, S Houghton, M Widell, A Grillner, L Persson, MAA
Citation: T. Allander et al., Recombinant human monoclonal antibodies against different conformational epitopes of the E2 envelope glycoprotein of hepatitis C virus that inhibit its interaction with CD81, J GEN VIROL, 81, 2000, pp. 2451-2459
Global surveillance and control of hepatitis C
Authors: Lavanchy, D Purcell, R Hollinger, FB Howard, C Alberti, A Kew, M Dusheiko, G Alter, M Ayoola, E Beutels, P Bloomer, R Ferret, B Decker, R Esteban, R Fay, O Fields, H Fuller, EC Grob, P Houghton, M Leung, N Locarnini, SA Margolis, H Meheus, A Miyamura, T Mohamed, MK Tandon, B Thomas, D Head, HT Toukan, AU Van Damme, P Zanetti, A Arthur, R Couper, M D'Amelio, R Emmanuel, JC Esteves, K Gavinio, P Griffiths, E Hallaj, Z Heuck, CC Heymann, DL Holck, SE Kane, M Martinez, LJ Meslin, F Mochny, IS Ndikuyeze, A Padilla, AM Rodier, GRM Roure, C Savage, F Vercauteren, G
Citation: D. Lavanchy et al., Global surveillance and control of hepatitis C, J VIRAL HEP, 6(1), 1999, pp. 35-47
Analysis of a successful immune response against hepatitis C virus
Authors: Cooper, S Erickson, AL Adams, EJ Kansopon, J Weiner, AJ Chien, DY Houghton, M Parham, P Walker, CM
Citation: S. Cooper et al., Analysis of a successful immune response against hepatitis C virus, IMMUNITY, 10(4), 1999, pp. 439-449
Comparison of secretion of a hepatitis C virus glycoprotein in Saccharomyces cerevisiae and Kluyveromyces lactis
Authors: Mustilli, AC Izzo, E Houghton, M Galeotti, CL
Citation: Ac. Mustilli et al., Comparison of secretion of a hepatitis C virus glycoprotein in Saccharomyces cerevisiae and Kluyveromyces lactis, RES MICROB, 150(3), 1999, pp. 179-187
High prevalence of G1 and G2 TT-virus infection in subjects with high and low blood exposure risk: identification of G4 isolates in Italy
Authors: Colombatto, P Brunetto, MR Kansopon, J Oliveri, F Maina, A Aragon, U Bortoli, ML Scatena, F Baicchi, U Houghton, M Bonino, F Weiner, AJ
Citation: P. Colombatto et al., High prevalence of G1 and G2 TT-virus infection in subjects with high and low blood exposure risk: identification of G4 isolates in Italy, J HEPATOL, 31(6), 1999, pp. 990-996
Perspectives for a vaccine against hepatitis C virus
Authors: Abrignani, S Houghton, M Hsu, HH
Citation: S. Abrignani et al., Perspectives for a vaccine against hepatitis C virus, J HEPATOL, 31, 1999, pp. 259-263
Activation of the grp78 and grp94 promoters by hepatitis C virus E2 envelope protein
Authors: Liberman, E Fong, YL Selby, MJ Choo, QL Cousens, L Houghton, M Yen, TSB
Citation: E. Liberman et al., Activation of the grp78 and grp94 promoters by hepatitis C virus E2 envelope protein, J VIROLOGY, 73(5), 1999, pp. 3718-3722
Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules
Authors: Selby, M Erickson, A Dong, C Cooper, S Parham, P Houghton, M Walker, CM
Citation: M. Selby et al., Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules, J IMMUNOL, 162(2), 1999, pp. 669-676
Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation
Authors: Rosen, HR Hinrichs, DJ Gretch, DR Koziel, MJ Chou, S Houghton, M Rabkin, J Corless, CL Bouwer, HGA
Citation: Hr. Rosen et al., Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation, GASTROENTY, 117(4), 1999, pp. 926-932
Risultati: 1-22 |